Please wait
​October 29, 2025​ ​Chirantan J. Desai​ ​[via email]​ ​Dear CJ,​ ​MongoDB,​​Inc.​​(the​​“Company”)​​is​​delighted​​to​​confirm​​our​​employment​​offer​​for​​the​​position​​of​​President​​and​​Chief​ ​Executive​ ​Officer​ ​to​ ​be​​based​​in​​our​​New​​York​​and​​Palo​​Alto​​offices​​(with​​travel​​to​​other​​offices​​from​​time​​to​​time),​ ​reporting​​to​​the​​Company’s​​Board​​of​​Directors​​(the​​“Board”).​ ​You​​will​ ​also​​be​​appointed​​to​​the​​Company’s​​Board​​as​ ​an​ ​executive​ ​member​ ​of​ ​the​ ​Board.​ ​If​ ​you​ ​accept​ ​our​ ​offer,​ ​the​ ​terms​ ​and​ ​conditions​ ​set​ ​forth​ ​in​ ​this​ ​offer​ ​letter​ ​agreement​​(the​​“Agreement”)​​will​ ​become​​effective​​as​​of​​November​​10,​​2025​​or​​later​​date​​mutually​​agreed​​with​​the​ ​Company (the “Effective Date”).​ ​Base Salary​ ​You​​will​ ​be​​employed​​as​​a​​full-time​​salaried​​employee,​​compensated​​at​​the​​rate​​of​​$20,833.33​​per​​semi-monthly​​pay​ ​period​​($500,000​​annually).​​Currently,​​the​​Company’s​​regular​​pay​​dates​​are​​the​​15th​​and​​last​​day​​of​​each​​calendar​ ​month.​​If​​a​​pay​​date​​falls​​on​​a​​weekend​​or​​Federal/bank​​holiday,​​then​​the​​pay​​date​​will​​be​​on​​the​​previous​​business​ ​day.​ ​Said​ ​salary​ ​will​ ​be​ ​paid​​in​​accordance​​with​​the​​Company’s​​normal​​payroll​​practices​​as​​may​​exist​​from​​time​​to​ ​time and is subject to required and voluntary withholdings.​ ​Bonus​ ​In​​addition​​to​​your​​base​​salary,​​during​​your​​employment​​as​​President​​and​​Chief​​Executive​​Officer,​​you​​will​​continue​​to​ ​be​​eligible​​for​​an​​annual​​bonus​​with​​a​​target​​of​​$350,000​​(or​​70%​​of​​base​​salary)​​per​​annum​​paid​​semi-annually,​​and​ ​which​ ​will​ ​be​ ​based​ ​on​ ​achievement​ ​of​​Company​​performance​​goals​​to​​be​​determined​​by​​the​​Company​​in​​its​​sole​ ​discretion.​​Bonus​​is​​subject​​to​​required​​and​​voluntary​​withholdings​​and​​paid​​according​​to​​Company​​payroll​​practices.​ ​You​ ​must​ ​be​ ​employed​ ​on​ ​the​ ​bonus​ ​payment​ ​date​ ​to​ ​be​ ​eligible​ ​for​ ​the​ ​bonus​ ​payment,​ ​except​ ​as​ ​otherwise​ ​provided below.​ ​Sign on Cash and Equity​ ​You​​will​​be​​entitled​​to​​a​​sign​​on​​bonus​​of​​$2,500,000,​​payable​​in​​cash:​​fifty​​percent​​($1,250,000)​​following​​six​​months​ ​of​​continuous​​service​​from​​the​​Effective​​Date​​and​​the​​remaining​​fifty​​percent​​($1,250,000)​​following​​twelve​​months​​of​ ​continuous​​service​​from​​the​​Effective​​Date,​​in​​each​​case,​​within​​the​​next​​applicable​​payroll​​cycle​​following​​each​​such​ ​payment vesting date.​ ​You​ ​will​ ​also​ ​be​ ​entitled​ ​to​ ​receive​ ​a​ ​Restricted​ ​Stock​ ​Unit​ ​award​ ​for​ ​shares​ ​of​ ​the​ ​Company’s​ ​Common​ ​Stock​ ​(“RSUs”)​​with​​a​​value​​as​​of​​the​​grant​​date​​of​​fifteen​​million​​US​​Dollars​​($15,000,000),​​with​​the​​number​​of​​RSUs​​to​​be​ ​determined​ ​by​ ​the​ ​Compensation​ ​Committee​ ​of​ ​the​ ​Board​ ​(the​ ​“Committee”),​ ​based​ ​on​ ​the​ ​closing​ ​price​ ​of​ ​the​ ​Company’s​ ​stock​ ​on​ ​October​ ​27,​ ​2025,​ ​subject​ ​to​ ​Committee​ ​approval​ ​and​ ​other​ ​terms​ ​and​ ​conditions​ ​of​ ​the​ ​Company’s​ ​2016​ ​Equity​ ​Incentive​ ​Plan​ ​and​ ​the​ ​related​ ​Restricted​ ​Stock​ ​Unit​ ​Award​​Grant​​Notice​​and​​Restricted​ ​Stock​​Unit​​Agreement.​​The​​RSUs​​will​ ​vest​​in​​eight​​equal​​quarterly​​installments​​over​​two​​(2)​​years​​starting​​after​​the​ ​first​ ​quarter​ ​following​ ​the​ ​Vesting​ ​Start​ ​Date​ ​(as​ ​set​ ​forth​ ​in​ ​the​ ​applicable​ ​award​ ​agreement),​ ​subject​ ​to​ ​your​ ​continuous​​service​​through​​each​​applicable​​vesting​​date​​such​​that​​100%​​of​​the​​RSUs​​will​​be​​vested​​on​​the​​two-year​ ​anniversary​​of​​the​​Vesting​​Start​​Date.​​Each​​RSU​​installment​​shall​​be​​subject​​to​​a​​one​​year​​holding​​period​​such​​that,​ ​following​​the​​vesting​​of​​each​​RSU​​installment,​​you​​agree​​not​​to​​sell,​​trade​​or​​otherwise​​dispose​​of​​such​​RSUs​​for​​an​ ​additional one year period following each such vesting date.​ Exhibit 10.2

 
​You​ ​will​ ​also​ ​be​ ​entitled​ ​to​ ​receive​​a​​Performance​​Stock​​Unit​​award​​for​​shares​​of​​the​​Company’s​​Common​​Stock​ ​(“PSUs”)​​with​​a​​value​​as​​of​​October​​27,​​2025,​​of​​seventeen​​million​​five​​hundred​​thousand​​US​​Dollars​​($17,500,000),​ ​with​​the​​number​​of​​PSUs​​to​​be​​determined​​by​​the​​Committee​​based​​on​​the​​closing​​price​​of​​the​​Company’s​​stock​​on​ ​October​​27,​​2025,​​as​​determined​​by​​the​​Committee,​​subject​​to​​Committee​​approval​​and​​other​​terms​​and​​conditions​ ​of​ ​the​ ​Company’s​ ​2016​ ​Equity​ ​Incentive​ ​Plan​ ​and​ ​the​ ​related​ ​Performance​ ​Stock​ ​Unit​ ​Award​ ​Grant​ ​Notice​ ​and​ ​Performance​ ​Stock​ ​Unit​ ​Agreement.​ ​Your​ ​grant​​will​ ​vest​​over​​three​​(3)​​years​​with​​a​​minimum​​one​​year​​time​​vest.​ ​Your​ ​grant​ ​will​ ​vest​ ​on​ ​the​ ​three​ ​year​ ​anniversary​ ​of​ ​the​ ​Vesting​ ​Start​ ​Date,​ ​subject​ ​to​ ​your​ ​continuous​ ​service​ ​through​​such​​vesting​​date,​​with​​the​​number​​of​​PSUs​​to​​be​​determined​​based​​on​​the​​Company’s​​performance​​(with​ ​such metrics as determined by the Committee).​ ​Equity​ ​You will be eligible to receive annual refresh grants based on performance.​ ​Termination​ ​Except​ ​as​ ​provided​ ​below,​ ​if​ ​you​ ​resign​ ​or​ ​the​ ​Company​ ​terminates​ ​your​ ​employment,​ ​or​ ​upon​ ​your​ ​death​ ​or​ ​disability,​​then​​(i)​​you​​will​ ​no​​longer​​vest​​in​​any​​equity​​awards,​​(ii)​​all​ ​payments​​of​​compensation​​by​​the​​Company​​to​ ​you​​hereunder​​will​ ​terminate​​immediately​​(except​​as​​to​​amounts​​already​​earned),​​and​​(iii)​​you​​will​ ​not​​be​​entitled​​to​ ​any​​severance​​benefits.​​In​​addition,​​you​​will​​resign​​from​​all​​positions​​and​​terminate​​any​​relationships​​as​​an​​employee,​ ​advisor, officer or director with the Company and any of its affiliates, each effective on the date of termination.​ ​In​ ​the​ ​event​ ​your​ ​employment​ ​with​​the​​Company​​is​​terminated​​by​​the​​Company​​without​​Cause​​(and​​other​​than​​as​ ​result​ ​of​ ​death​ ​or​​disability)​​or​​due​​to​​your​​resignation​​for​​Good​​Reason​​(collectively,​​an​​“Involuntary​​Termination”),​ ​then​ ​provided​ ​such​ ​Involuntary​ ​Termination​ ​constitutes​ ​a​ ​“separation​ ​from​ ​service”​ ​(as​ ​defined​ ​under​ ​Treasury​ ​Regulation​​Section​​1.409A-1(h),​​without​​regard​​to​​any​​alternative​​definition​​thereunder,​​a​​“Separation​​from​​Service”),​ ​and​​provided​​that​​you​​remain​​in​​compliance​​with​​the​​terms​​of​​this​​Agreement,​​the​​Company​​will​​provide​​you​​with​​the​ ​following​ ​severance​ ​benefits​ ​(collectively,​ ​the​ ​“Severance​​Benefits”):​​(a)​​an​​amount​​equal​​to​​twelve​​(12)​​months​​of​ ​your​ ​then-current​ ​base​ ​salary​ ​to​ ​be​ ​paid​​in​​equal​​installments​​on​​the​​Company’s​​normal​​payroll​​schedule​​over​​the​ ​twelve​​(12)​​month​​period​​immediately​​following​​the​​date​​of​​Separation​​from​​Service;​​and​​(b)​​provided​​that​​you​​timely​ ​elect​ ​continued​ ​coverage​ ​under​ ​COBRA,​​the​​Company​​will​ ​pay​​your​​COBRA​​premiums​​to​​continue​​your​​coverage​ ​(including​ ​coverage​ ​for​ ​eligible​ ​dependents,​ ​if​ ​applicable)​ ​(“COBRA​ ​Premiums”)​ ​through​ ​the​ ​period​ ​(the​ ​“COBRA​ ​Premium​​Period”)​​starting​​on​​your​​Separation​​from​​Service​​date​​and​​ending​​on​​the​​earliest​​to​​occur​​of:​​(i)​​twelve​​(12)​ ​months​​following​​your​​Separation​​from​​Service;​​(ii)​​the​​date​​you​​become​​eligible​​for​​group​​health​​insurance​​coverage​ ​through​​a​​new​​employer;​​or​​(iii)​​the​​date​​you​​cease​​to​​be​​eligible​​for​​COBRA​​continuation​​coverage​​for​​any​​reason,​ ​including​ ​plan​ ​termination.​ ​In​ ​the​ ​event​ ​you​ ​become​ ​covered​ ​under​ ​another​ ​employer's​ ​group​ ​health​ ​plan​ ​or​ ​otherwise​ ​cease​ ​to​ ​be​ ​eligible​ ​for​ ​COBRA​ ​during​ ​the​ ​COBRA​ ​Premium​ ​Period,​ ​you​ ​must​ ​immediately​ ​notify​ ​the​ ​Company​ ​of​ ​such​ ​event.​ ​Notwithstanding​ ​the​ ​foregoing,​ ​if​ ​the​ ​Company​ ​determines,​ ​in​ ​its​ ​sole​ ​discretion,​ ​that​ ​it​ ​cannot​​pay​​the​​COBRA​​Premiums​​without​​a​​substantial​​risk​​of​​violating​​applicable​​law​​(including,​​without​​limitation,​ ​Section​ ​2716​ ​of​ ​the​ ​Public​ ​Health​ ​Service​ ​Act),​ ​the​ ​Company​ ​will​ ​in​​lieu​​thereof​​provide​​to​​you​​a​​taxable​​monthly​ ​payment​ ​in​ ​an​ ​amount​ ​equal​ ​to​ ​the​ ​monthly​ ​COBRA​ ​premium​​that​​you​​would​​be​​required​​to​​pay​​to​​continue​​your​ ​group​ ​health​ ​coverage​ ​in​ ​effect​ ​on​ ​the​ ​date​ ​of​ ​your​ ​employment​ ​termination​ ​(which​ ​amount​ ​will​ ​be​​based​​on​​the​ ​premium​ ​for​ ​the​ ​first​ ​month​ ​of​ ​COBRA​ ​coverage),​ ​which​ ​payments​ ​will​ ​be​ ​made​ ​on​ ​the​ ​last​ ​day​ ​of​ ​each​ ​month​ ​regardless​​of​​whether​​you​​elect​​COBRA​​continuation​​coverage​​and​​will​​end​​on​​the​​earlier​​of​​(x)​​the​​date​​upon​​which​ ​you​ ​obtain​ ​other​ ​employment​ ​or​​(y)​​the​​last​​day​​of​​the​​12​​th​ ​calendar​​month​​following​​your​​Separation​​from​​Service​ ​date.​ ​If​ ​your​ ​Involuntary​ ​Termination​ ​occurs​ ​either​ ​in​​connection​​with​​a​​Change​​in​​Control​​(as​​defined​​in​​the​​Company’s​ ​2016​​Equity​​Incentive​​Plan),​​or​​within​​3​​months​​prior​​to​​or​​within​​twelve​​(12)​​months​​following​​the​​closing​​of​​a​​Change​ ​in​​Control,​​and​​such​​termination​​qualifies​​as​​a​​Separation​​from​​Service,​​and​​provided​​that​​you​​remain​​in​​compliance​ ​with​ ​the​ ​terms​ ​of​ ​this​ ​Agreement,​ ​then​ ​you​ ​will​ ​be​ ​entitled​ ​to​​the​​Severance​​Benefits​​provided​​for​​above,​​and​​the​ ​following​ ​additional​ ​benefits:​ ​(a)​ ​an​​amount​​equal​​to​​twelve​​(12)​​months​​of​​your​​then-current​​“cash​​eligible”​​annual​ ​target​​bonus​​to​​be​​paid​​in​​equal​​installments​​on​​the​​Company’s​​normal​​payroll​​schedule​​over​​the​​twelve​​(12)​​month​ ​period​ ​immediately​ ​following​ ​the​ ​date​ ​of​ ​Separation​ ​from​ ​Service,​ ​which,​ ​for​ ​the​ ​avoidance​ ​of​ ​doubt,​ ​shall​ ​be​ ​in​ ​addition​​to​​payment​​of​​(i)​​any​​earned​​but​​unpaid​​annual​​bonus​​for​​the​​fiscal​​year​​preceding​​the​​fiscal​​year​​in​​which​ ​such​​Separation​​from​​Service​​occurs​​based​​on​​actual​​performance,​​as​​determined​​by​​the​​Compensation​​Committee​ ​and​ ​(ii)​ ​an​ ​annual​ ​bonus​ ​for​ ​the​ ​fiscal​ ​year​ ​in​ ​which​ ​the​​Separation​​from​​Service​​occurs,​​prorated​​to​​your​​date​​of​ ​Separation​​from​​Service​​and​​determined​​based​​on​​the​​greater​​of​​target​​performance​​or​​actual​​performance​​as​​of​​your​ ​date​ ​of​ ​Separation​ ​from​ ​Service​​,​ ​as​ ​determined​ ​by​ ​the​ ​Compensation​ ​Committee​​;​ ​(b)​ ​100%​ ​of​ ​all​ ​of​ ​your​ ​then-outstanding​ ​time-based​ ​unvested​ ​Company​ ​equity​ ​awards​ ​will​ ​accelerate​ ​and​ ​will​ ​be​ ​deemed​ ​vested​ ​and​ Exhibit 10.2

 
​exercisable​ ​(if​ ​applicable)​ ​as​​of​​your​​date​​of​​Separation​​from​​Service;​​and​​(c)​​100%​​of​​all​ ​of​​your​​then-outstanding​ ​performance-based​​unvested​​Company​​equity​​awards​​will​ ​accelerate​​and​​will​ ​be​​deemed​​vested​​and​​exercisable​​(if​ ​applicable)​​based​​on​​the​​greater​​of​​your​​target​​performance​​rate​​or​​actual​​performance​​as​​of​​your​​date​​of​​Separation​ ​from​ ​Service​​(collectively,​​the​​“Change​​in​​Control​​Severance​​Benefits”),​​including​​any​​performance-based​​unvested​ ​awards​ ​granted​ ​pursuant​ ​to​ ​the​ ​Company’s​ ​Senior​ ​Leadership​ ​Equity​ ​Bonus​ ​Program​ ​(or​ ​similar​ ​annual​ ​bonus​ ​program​ ​that​ ​may​ ​be​ ​adopted​ ​in​ ​the​​future)​​(an​​“Equity​​Bonus​​Program”).​​For​​the​​avoidance​​of​​doubt,​​if​ ​you​​have​ ​elected​ ​to​ ​receive​ ​your​ ​annual​ ​bonus​ ​in​ ​equity​ ​in​ ​lieu​ ​of​ ​cash​ ​pursuant​ ​to​ ​an​ ​Equity​ ​Bonus​ ​Program,​ ​and​ ​have​ ​received​ ​an​ ​equity​ ​grant​ ​as​ ​a​ ​result​ ​of​ ​this​ ​election,​ ​your​ ​annual​ ​bonus​ ​for​​the​​performance​​period​​for​​which​​you​ ​made​ ​the​ ​election​ ​will​ ​no​ ​longer​ ​be​ ​considered​ ​“cash-eligible”​ ​for​ ​purposes​ ​of​ ​subsection​ ​(a)​ ​of​ ​this​ ​paragraph;​ ​provided​ ​however,​ ​that​ ​for​ ​any​ ​period​ ​for​ ​which​​you​​have​​elected​​to​​receive​​your​​annual​​bonus​​in​​equity​​in​​lieu​​of​ ​cash​​pursuant​​to​​an​​Equity​​Bonus​​Program,​​and​​for​​which​​the​​Company​​has​​not​​yet​​granted​​an​​equity​​award​​to​​you​ ​as​​of​​the​​date​​of​​Separation​​of​​Service,​​then​​such​​election​​shall​​be​​void,​​and​​your​​annual​​bonus​​for​​such​​period​​shall​ ​be “cash-eligible” in accordance with subsection (a) of this paragraph.​ ​The​​receipt​​of​​the​​Severance​​Benefits​​or​​the​​Change​​in​​Control​​Severance​​Benefits,​​as​​applicable,​​provided​​above​ ​will​ ​be​​subject​​to​​you​​signing​​and​​not​​revoking​​a​​separation​​agreement​​and​​release​​of​​claims​​in​​a​​form​​similar​​to​​that​ ​attached​​hereto​​as​​Exhibit​​A​​(as​​amended​​to​​reflect​​the​​reason​​for​​the​​separation​​and​​any​​changes​​to​​the​​law)​​(the​ ​“Separation​​Agreement”)​​within​​the​​time​​period​​set​​forth​​therein,​​which​​will​​not​​exceed​​50​​days​​from​​the​​date​​of​​your​ ​Separation​​from​​Service​​(the​​“Release​​Period”).​​No​​Severance​​Benefits​​or​​Change​​in​​Control​​Severance​​Benefits,​​as​ ​applicable,​ ​will​ ​be​ ​paid​ ​or​ ​provided​ ​until​ ​the​ ​Separation​ ​Agreement​ ​becomes​ ​effective.​ ​If​ ​the​ ​Release​ ​Period​ ​described​ ​in​ ​the​ ​preceding​ ​sentence​ ​spans​ ​two​ ​calendar​ ​years,​ ​then​ ​payment​ ​of​ ​the​ ​Severance​ ​Benefits​ ​or​ ​the​ ​Change​​in​​Control​​Severance​​Benefits,​​as​​applicable,​​will​ ​in​​any​​event​​commence​​in​​the​​second​​calendar​​year.​​You​ ​will​ ​also​​resign​​from​​all​​positions​​and​​terminate​​any​​relationships​​as​​an​​employee,​​advisor,​​officer​​or​​director​​with​​the​ ​Company and any of its affiliates, each effective on the date of termination.​ ​For​ ​purposes​ ​of​ ​this​ ​Agreement,​ ​“Cause”​ ​will​ ​mean​ ​termination​ ​based​ ​upon​ ​(i)​ ​your​ ​willful​ ​failure​ ​to​ ​follow​​lawful​ ​directions​ ​communicated​​to​​you​​by​​the​​Board​​or​​otherwise​​to​​perform​​your​​duties​​to​​the​​Company;​​(ii)​​the​​willful​​or​ ​intentional​ ​engaging​ ​by​ ​you​ ​in​ ​conduct​ ​which​ ​is​ ​injurious​ ​to​ ​the​ ​Company​ ​or​ ​its​ ​reputation,​ ​business​​or​​business​ ​relationships,​​monetarily​​or​​otherwise;​​(iii)​​your​​commission​​of​​an​​act​​of​​fraud,​​misappropriation​​or​​embezzlement​​with​ ​respect​​to​​the​​Company​​or​​the​​Company's​​business;​​(iv)​​your​​conviction​​of,​​or​​a​​plea​​of​​guilty​​or​​nolo​​contendere​​to,​​a​ ​felony​​or​​a​​crime​​of​​moral​​turpitude​​(meaning​​an​​extreme​​departure​​from​​ordinary​​standards​​of​​honesty,​​good​​morals,​ ​justice​​or​​ethics​​as​​to​​be​​shocking​​in​​the​​moral​​sense​​of​​community);​​(v)​​your​​habitual​​drunkenness​​or​​use​​of​​illegal​ ​substances;​​(vi)​​a​​material​​breach​​by​​you​​of​​your​​obligations​​under​​this​​Agreement,​​including​​(without​​limitation)​​your​ ​obligations​ ​specified​ ​in​ ​your​​Employee​​Invention​​Assignment​​Agreement,​​Confidentiality​​and​​Arbitration​​Agreement​ ​that​ ​is​ ​not​ ​cured​ ​(to​ ​the​ ​extent​ ​curable)​ ​within​ ​15​ ​days​ ​of​ ​the​ ​Company​ ​providing​ ​written​ ​notice​ ​of​ ​such​​material​ ​breach;​​or​​(vii)​​your​​commission​​of​​an​​act​​of​​gross​​neglect​​or​​gross​​misconduct​​in​​connection​​with​​the​​performance​​of​ ​your duties.​ ​For​ ​purposes​​of​​this​​Agreement,​​“Good​​Reason”​​means​​the​​occurrence​​of​​one​​of​​the​​following​​events​​without​​your​ ​written​​consent:​​(i)​​a​​material​​diminution​​by​​the​​Company​​in​​your​​title​​or​​the​​nature​​or​​scope​​of​​your​​responsibilities,​ ​duties​​or​​authority​​with​​the​​Company,​​it​​being​​specified​​that​​no​​longer​​holding​​the​​office​​of​​Chief​​Executive​​Officer​​of​​a​ ​publicly​​traded​​company​​will​​be​​considered​​a​​material​​diminution​​in​​responsibilities​​under​​this​​clause​​(i),​​(ii)​​a​​material​ ​reduction​ ​of​ ​your​ ​base​ ​salary,​ ​(iii)​ ​a​ ​relocation​ ​of​ ​your​ ​principal​​place​​of​​employment​​that​​increases​​your​​one-way​ ​commute​ ​by​ ​more​ ​than​ ​50​ ​miles​ ​as​ ​compared​ ​to​ ​your​ ​then-current​ ​principal​ ​place​ ​of​ ​employment​ ​prior​ ​to​ ​such​ ​relocation​ ​(it​ ​being​ ​understood​ ​that​ ​you​ ​are​ ​expected​ ​to​ ​spend​ ​material​ ​amounts​ ​of​ ​time​ ​in​ ​the​ ​Company’s​​other​ ​offices​ ​as​​part​​of​​your​​duties​​hereunder),​​or​​(iv)​​failure​​by​​the​​Company​​to​​ensure​​that​​a​​successor​​entity​​assumes​ ​this​ ​Agreement;​ ​provided,​ ​however,​ ​that​ ​to​ ​resign​ ​for​ ​Good​ ​Reason,​ ​you​ ​must​ ​(1)​ ​provide​ ​written​ ​notice​ ​to​ ​the​ ​Company’s​​General​​Counsel​​within​​30​​days​​after​​the​​first​​occurrence​​of​​the​​event​​giving​​rise​​to​​Good​​Reason​​setting​ ​forth​​the​​basis​​for​​your​​resignation,​​(2)​​allow​​the​​Company​​at​​least​​30​​days​​from​​receipt​​of​​such​​written​​notice​​to​​cure​ ​such​ ​event,​ ​and​ ​(3)​ ​if​ ​such​ ​event​​is​​not​​reasonably​​cured​​with​​such​​period,​​your​​resignation​​from​​all​​positions​​you​ ​then hold with the Company is effective not later than 60 days after the expiration of the cure period.​ ​Benefits​ ​As​​a​​regular​​full-time​​employee,​​you​​will​​continue​​to​​be​​eligible​​to​​participate​​in​​Company-sponsored​​medical,​​dental,​ ​vision,​​life​​insurance,​​short​​and​​long-term​​disability​​plans.​​The​​Company​​may​​discontinue​​or​​modify​​any​​such​​plans,​ ​programs or practices at any time, with or without notice.​ Exhibit 10.2

 
​Section 280G​ ​If​​any​​payment​​or​​benefit​​(including​​payments​​and​​benefits​​pursuant​​to​​this​​Agreement)​​that​​you​​would​​receive​​from​ ​the​​Company​​or​​otherwise​​in​​connection​​with​​a​​Change​​in​​Control​​(the​​“Transaction​​Payment”)​​would​​(i)​​constitute​​a​ ​“parachute​ ​payment”​ ​within​ ​the​​meaning​​of​​Section​​280G​​of​​the​​Internal​​Revenue​​Code​​of​​1986,​​as​​amended​​(the​ ​“Code”)​​and​​(ii)​​but​​for​​this​​sentence,​​be​​subject​​to​​the​​excise​​tax​​imposed​​by​​Section​​4999​​of​​the​​Code​​(the​​“Excise​ ​Tax”),​ ​then​ ​the​ ​Company​​will​ ​cause​​to​​be​​determined,​​before​​any​​amounts​​of​​the​​Transaction​​Payment​​are​​paid​​to​ ​you,​​which​​of​​the​​following​​two​​alternative​​forms​​of​​payment​​would​​result​​in​​your​​receipt,​​on​​an​​after-tax​​basis,​​of​​the​ ​greater​​amount​​of​​the​​Transaction​​Payment​​notwithstanding​​that​​all​​or​​some​​portion​​of​​the​​Transaction​​Payment​​may​ ​be​​subject​​to​​the​​Excise​​Tax:​​(1)​​payment​​in​​full​ ​of​​the​​entire​​amount​​of​​the​​Transaction​​Payment​​(a​​“Full​​Payment”),​ ​or​​(2)​​payment​​of​​only​​a​​part​​of​​the​​Transaction​​Payment​​so​​that​​you​​receive​​the​​largest​​payment​​possible​​without​​the​ ​imposition​​of​​the​​Excise​​Tax​​(a​​“Reduced​​Payment”).​​For​​purposes​​of​​determining​​whether​​to​​make​​a​​Full​​Payment​​or​ ​a​​Reduced​​Payment,​​the​​Company​​will​ ​cause​​to​​be​​taken​​into​​account​​all​​applicable​​federal,​​state​​and​​local​​income​ ​and​​employment​​taxes​​and​​the​​Excise​​Tax​​(all​​computed​​at​​the​​highest​​applicable​​marginal​​rate,​​net​​of​​the​​maximum​ ​reduction​ ​in​ ​federal​ ​income​ ​taxes​ ​which​ ​could​ ​be​ ​obtained​ ​from​ ​a​ ​deduction​ ​of​ ​such​ ​state​ ​and​ ​local​ ​taxes).​ ​If​ ​a​ ​Reduced​ ​Payment​ ​is​ ​made,​ ​(x)​ ​you​ ​will​ ​have​ ​no​​rights​​to​​any​​additional​​payments​​and/or​​benefits​​constituting​​the​ ​Transaction​ ​Payment,​ ​and​ ​(y)​ ​reduction​ ​in​ ​payments​ ​and/or​ ​benefits​ ​will​ ​occur​ ​in​ ​the​ ​manner​ ​that​ ​results​ ​in​ ​the​ ​greatest​​economic​​benefit​​to​​you​​as​​determined​​in​​this​​paragraph.​​If​​more​​than​​one​​method​​of​​reduction​​will​​result​​in​ ​the​ ​same​ ​economic​ ​benefit,​ ​the​ ​portions​ ​of​​the​​Transaction​​Payment​​will​ ​be​​reduced​​pro​​rata.​​Unless​​you​​and​​the​ ​Company​ ​otherwise​ ​agree​ ​in​ ​writing,​ ​any​ ​determination​ ​required​ ​under​ ​this​ ​section​ ​will​ ​be​​made​​in​​writing​​by​​the​ ​Company’s​​independent​​public​​accountants​​(the​​“Accountants”),​​whose​​determination​​will​​be​​conclusive​​and​​binding​ ​upon​ ​you​ ​and​ ​the​ ​Company​​for​​all​ ​purposes.​​For​​purposes​​of​​making​​the​​calculations​​required​​by​​this​​section,​​the​ ​Accountants​ ​may​ ​make​ ​reasonable​ ​assumptions​​and​​approximations​​concerning​​applicable​​taxes​​and​​may​​rely​​on​ ​reasonable,​ ​good​ ​faith​​interpretations​​concerning​​the​​application​​of​​Sections​​280G​​and​​4999​​of​​the​​Code.​​You​​and​ ​the​ ​Company​ ​will​ ​furnish​ ​to​ ​the​​Accountants​​such​​information​​and​​documents​​as​​the​​Accountants​​may​​reasonably​ ​request​ ​in​​order​​to​​make​​a​​determination​​under​​this​​section.​​The​​Company​​will​ ​bear​​all​ ​costs​​the​​Accountants​​may​ ​reasonably​ ​incur​ ​in​ ​connection​ ​with​​any​​calculations​​contemplated​​by​​this​​section​​as​​well​​as​​any​​costs​​incurred​​by​ ​you with the Accountants for tax planning under Sections 280G and 4999 of the Code.​ ​Section 409A​ ​It​ ​is​ ​intended​ ​that​ ​all​ ​of​ ​the​ ​severance​ ​benefits​ ​and​ ​other​ ​payments​ ​payable​ ​under​ ​this​ ​Agreement​​satisfy,​​to​​the​ ​greatest​​extent​​possible,​​the​​exemptions​​from​​the​​application​​of​​Section​​409A​​of​​the​​Code​​(“Section​​409A”)​​provided​ ​under​​Treasury​​Regulations​​1.409A-1(b)(4),​​1.409A-1(b)(5)​​and​​1.409A-1(b)(9),​​and​​this​​Agreement​​will​​be​​construed​ ​to​​the​​greatest​​extent​​possible​​as​​consistent​​with​​those​​provisions,​​and​​to​​the​​extent​​not​​so​​exempt,​​this​​Agreement​ ​(and​ ​any​ ​definitions​ ​hereunder)​ ​will​ ​be​ ​construed​ ​in​ ​a​ ​manner​ ​that​ ​complies​ ​with​ ​Section​ ​409A.​ ​For​ ​purposes​ ​of​ ​Section​​409A​​(including,​​without​​limitation,​​for​​purposes​​of​​Treasury​​Regulation​​Section​​1.409A-2(b)(2)(iii)),​​your​​right​ ​to​ ​receive​ ​any​ ​installment​ ​payments​ ​under​ ​this​ ​Agreement​ ​(whether​ ​severance​ ​payments,​ ​reimbursements​ ​or​ ​otherwise)​ ​will​ ​be​ ​treated​ ​as​ ​a​ ​right​ ​to​ ​receive​ ​a​ ​series​ ​of​ ​separate​ ​payments​ ​and,​ ​accordingly,​ ​each​ ​installment​ ​payment​​hereunder​​will​ ​at​​all​ ​times​​be​​considered​​a​​separate​​and​​distinct​​payment.​​Notwithstanding​​any​​provision​​to​ ​the​​contrary​​in​​this​​Agreement,​​if​ ​you​​are​​deemed​​by​​the​​Company​​at​​the​​time​​of​​your​​Separation​​from​​Service​​to​​be​ ​a​ ​“specified​ ​employee”​ ​for​ ​purposes​ ​of​ ​Section​ ​409A(a)(2)(B)(i),​​and​​if​​any​​of​​the​​payments​​upon​​Separation​​from​ ​Service​ ​set​ ​forth​ ​herein​ ​and/or​ ​under​ ​any​ ​other​ ​agreement​ ​with​ ​the​ ​Company​ ​are​ ​deemed​ ​to​ ​be​ ​“deferred​ ​compensation”,​ ​then​ ​to​ ​the​ ​extent​​delayed​​commencement​​of​​any​​portion​​of​​such​​payments​​is​​required​​in​​order​​to​ ​avoid​ ​a​ ​prohibited​​distribution​​under​​Section​​409A(a)(2)(B)(i)​​and​​the​​related​​adverse​​taxation​​under​​Section​​409A,​ ​such​​payments​​will​ ​not​​be​​provided​​to​​you​​prior​​to​​the​​earliest​​of​​(i)​​the​​expiration​​of​​the​​six-month​​period​​measured​ ​from​​the​​date​​of​​your​​Separation​​from​​Service​​with​​the​​Company,​​(ii)​​the​​date​​of​​your​​death​​or​​(iii)​​such​​earlier​​date​​as​ ​permitted​ ​under​ ​Section​ ​409A​ ​without​​the​​imposition​​of​​adverse​​taxation.​​Upon​​the​​first​​business​​day​​following​​the​ ​expiration​​of​​such​​time​​period,​​all​ ​payments​​deferred​​pursuant​​to​​this​​section​​will​ ​be​​paid​​in​​a​​lump​​sum​​to​​you,​​and​ ​any​​remaining​​payments​​due​​will​​be​​paid​​as​​otherwise​​provided​​herein​​or​​in​​the​​applicable​​agreement.​​No​​interest​​will​ ​be​ ​due​ ​on​ ​any​ ​amounts​ ​so​ ​deferred.​ ​Notwithstanding​ ​anything​ ​to​ ​the​ ​contrary​ ​in​ ​this​ ​Agreement,​ ​all​ ​(1)​ ​reimbursements​​and​​(2)​​in-kind​​benefits​​provided​​under​​this​​Agreement​​shall​​be​​made​​or​​provided​​in​​accordance​​with​ ​the​ ​requirements​ ​of​ ​Section​ ​409A,​ ​including,​ ​where​ ​applicable,​ ​the​ ​requirement​ ​that​ ​(x)​ ​the​ ​amount​ ​of​ ​expenses​ ​eligible​​for​​reimbursement,​​or​​in​​kind​​benefits​​provided,​​during​​a​​calendar​​year​​may​​not​​affect​​the​​expenses​​eligible​ ​for​​reimbursement,​​or​​in​​kind​​benefits​​to​​be​​provided,​​in​​any​​other​​calendar​​year;​​(y)​​the​​reimbursement​​of​​an​​eligible​ ​expense​ ​will​ ​be​ ​made​ ​no​ ​later​ ​than​ ​the​ ​last​ ​day​ ​of​ ​the​ ​calendar​ ​year​ ​following​ ​the​ ​year​ ​in​ ​which​ ​the​​expense​​is​ ​incurred;​ ​and​ ​(z)​​the​​right​​to​​reimbursement​​or​​in​​kind​​benefits​​is​​not​​subject​​to​​liquidation​​or​​exchange​​for​​another​ ​benefit.​ ​In​ ​no​ ​event​ ​whatsoever​ ​will​ ​the​ ​Company​ ​be​ ​liable​ ​for​ ​any​ ​additional​​tax,​​interest​​or​​penalty​​that​​may​​be​ ​imposed on you by Section 409A or damages for failing to comply with Section 409A.​ Exhibit 10.2

 
​Arbitration​ ​You​​and​​the​​Company​​have​​previously​​executed​​the​​Company’s​​standard​​arbitration​​agreement​​that​​is​​contained​​in​ ​your​​Employee​​Invention​​Assignment,​​Confidentiality​​and​​Arbitration​​Agreement​​(the​​“Arbitration​​Agreement”),​​which​ ​agreement​ ​remains​ ​in​ ​full​ ​force​ ​and​ ​effect.​ ​You​ ​acknowledge​ ​and​ ​agree​ ​to​ ​all​ ​of​ ​the​​Company’s​​policies​​in​​effect​ ​during​ ​your​ ​employment​ ​with​ ​Company,​ ​including,​​but​​not​​limited​​to,​​the​​policies​​found​​in​​the​​MongoDB​​Employee​ ​Handbook and the Arbitration Agreement.​ ​At Will Employment​ ​Your​​employment​​relationship​​with​​the​​Company​​is​​“at-will."​​That​​means​​you​​are​​free,​​at​​any​​time,​​for​​any​​reason,​​to​ ​end​ ​your​ ​employment​ ​with​ ​the​ ​Company​ ​and​ ​that​ ​the​ ​Company​ ​may​ ​do​ ​the​ ​same.​ ​Our​ ​agreement​ ​regarding​ ​employment-at-will may not be changed, except specifically in writing signed by the Board and you.​ ​We look forward to your continued contributions to the growth and success of MongoDB over the coming years.​ ​Sincerely,​ ​MongoDB, Inc.​ ​Name: Andrew Stephens​ ​Date​ ​Title: General Counsel​ ​I hereby acknowledge my acceptance of continued employment with MongoDB pursuant to the terms and conditions​ ​contained in this Agreement.​ ​Chirantan J. Desai​ ​Date​ Exhibit 10.2 /s/ Andrew Stephens October 29, 2025 /s/ Chirantan Desai October 29, 2025

 
​Exhibit A​ ​[DATE]​ ​CJ Desai​ ​Re:​​Terms of​​[Resignation or Separation]​ ​This​​letter​​confirms​​the​​agreement​​(“Agreement”)​​between​​you​​and​​MongoDB,​​Inc.​​(the​​“Company”)​​concerning​​the​ ​terms​​of​​your​​[resignation​​or​​separation]​​and​​offers​​you​​the​​separation​​compensation​​we​​discussed​​in​​exchange​​for​ ​a general release of claims and covenant not to sue.​ ​1.​​[​​Resignation​​or​​Separation]​ ​Date​​:​​is​​your​​last​​day​​of​​employment​​with​​the​​Company​​(the​​“​​[Resignation ​or Separation]​​Date”).​ ​2.​​Acknowledgment​​of​​Payment​​of​​Wages​​:​​On​​the​​next​​regularly​​scheduled​​pay​​day​​following​​the​​Separation ​Date,​​the​​Company​​will​​pay​​you​​an​​amount​​that​​represents​​all​​of​​your​​salary​​earned​​through​​the​​Separation​​Date.​​Per​ ​the​ ​Company’s​​flexible​​time​​off​​program,​​paid​​time​​off​​is​​not​​accrued​​and​​is​​therefore​​not​​paid​​out​​upon​​separation​ ​from​​the​​Company.​​You​​acknowledge​​that,​​prior​​to​​the​​execution​​of​​this​​Agreement,​​you​​were​​not​​entitled​​to​​receive​ ​any​ ​additional​ ​money​ ​from​ ​the​ ​Company,​ ​and​ ​that​​the​​only​​payments​​and​​benefits​​that​​you​​are​​entitled​​to​​receive​ ​from the Company in the future are those specified in this Agreement.​ ​3.​​Separation​ ​Compensation​​:​ ​In​ ​exchange​ ​for​ ​your​​agreement​​to​​the​​general​​release​​and​​waiver​​of​​claims ​and​​covenant​​not​​to​​sue​​set​​forth​​below​​and​​your​​other​​promises​​herein,​​the​​Company​​agrees​​to​​provide​​you​​with​​the​ ​[Severance​​Benefits​​/​​Change​​in​​Control​​Severance​​Benefits]​​(as​​defined​​in​​the​​Offer​​Letter,​​dated​​as​​of​​October​ ​29, 2025, between you and the Company).​ ​By​ ​signing​ ​below,​ ​you​ ​acknowledge​ ​that​ ​you​ ​are​ ​receiving​ ​the​ ​separation​ ​compensation​ ​outlined​ ​in​ ​this​ ​paragraph​ ​in​ ​consideration​ ​for​ ​waiving​ ​your​ ​rights​ ​to​ ​claims​ ​referred​ ​to​ ​in​ ​this​ ​Agreement​​and​​that​​you​​would​​not​ ​otherwise be entitled to the separation compensation.​ ​4.​​Return​​of​​Company​​Property​​:​​You​​hereby​​warrant​​to​​the​​Company​​that​​you​​have​​returned​​to​​the​​Company ​all property or data of the Company of any type whatsoever that has been in your possession or control.​ ​5.​​Proprietary​​Information:​​You​​hereby​​acknowledge​​that​​you​​are​​and​​continue​​to​​be​​bound​​by​​the​​attached ​Employee​​Invention​​Assignment,​​Confidentiality​​and​​Arbitration​​Agreement​​(​​Exhibit​​A​​hereto)​​and​​that​​as​​a​​result​​of​ ​your​ ​employment​ ​with​ ​the​​Company​​you​​have​​had​​access​​to​​the​​Company’s​​Proprietary​​Information​​(as​​defined​​in​ ​the​​agreement),​​that​​you​​will​ ​hold​​all​ ​Proprietary​​Information​​in​​strictest​​confidence​​and​​that​​you​​will​​not​​make​​use​​of​ ​such​ ​Proprietary​ ​Information​ ​on​ ​behalf​ ​of​ ​anyone.​ ​You​ ​further​ ​confirm​​that​​you​​have​​delivered​​to​​the​​Company​​all​ ​documents​ ​and​ ​data​ ​of​ ​any​ ​nature​ ​containing​ ​or​ ​pertaining​ ​to​ ​such​​Proprietary​​Information​​and​​that​​you​​have​​not​ ​taken with you any such documents or data or any reproduction thereof.​ ​6.​​Equity​​:​ ​Pursuant​ ​to​ ​your​ ​award​ ​agreements​ ​with​ ​the​ ​Company​ ​dated​ ​[_____________]​ ​and​ ​the ​Company's​ ​2016​​Equity​​Incentive​​Plan​​(hereafter​​collectively​​referred​​to​​as​​the​​“Award​​Agreements”),​​you​​received​ ​certain​ ​equity​ ​awards.​ ​Your​ ​rights​ ​concerning​ ​any​ ​equity​ ​awards​ ​will​ ​be​ ​governed​ ​by​ ​the​ ​applicable​ ​Award​ ​Agreements, except as otherwise set forth in your Offer Letter.​ ​7.​​General Release and Waiver of Claims​​: ​a. ​The​ ​payments​ ​and​ ​promises​ ​set​ ​forth​ ​in​ ​this​​Agreement​​are​​in​​full​ ​satisfaction​​of​​all​ ​accrued ​salary,​​vacation​​pay,​​bonus​​and​​commission​​pay,​​profit-sharing,​​stock,​​stock​​options​​or​​other​​ownership​​interest​​in​​the​ Exhibit 10.2

 
​Company,​​termination​​benefits​​or​​other​​compensation​​to​​which​​you​​may​​be​​entitled​​by​​virtue​​of​​your​​employment​​with​ ​the​ ​Company​​or​​your​​separation​​from​​the​​Company.​​To​​the​​fullest​​extent​​permitted​​by​​law,​​you​​hereby​​release​​and​ ​waive​ ​any​ ​other​ ​claims​ ​you​ ​may​ ​have​ ​against​ ​the​ ​Company​ ​and​ ​its​ ​owners,​ ​agents,​ ​officers,​ ​shareholders,​ ​employees,​ ​directors,​ ​attorneys,​ ​subscribers,​ ​subsidiaries,​ ​affiliates,​ ​successors​ ​and​ ​assigns​ ​(collectively​ ​“Releasees”),​ ​whether​ ​known​ ​or​ ​not​ ​known,​ ​including,​ ​without​ ​limitation,​ ​claims​ ​under​ ​any​ ​employment​ ​laws,​ ​including,​​but​​not​​limited​​to,​​claims​​of​​unlawful​​discharge,​​breach​​of​​contract,​​breach​​of​​the​​covenant​​of​​good​​faith​​and​ ​fair​ ​dealing,​ ​fraud,​ ​violation​ ​of​ ​public​ ​policy,​ ​defamation,​ ​physical​ ​injury,​ ​emotional​ ​distress,​ ​claims​ ​for​ ​additional​ ​compensation​​or​​benefits​​arising​​out​​of​​your​​employment​​or​​your​​separation​​of​​employment,​​claims​​under​​Title​​VII​​of​ ​the​ ​1964​ ​Civil​ ​Rights​ ​Act,​ ​as​ ​amended,​ ​the​ ​New​ ​York​ ​Human​ ​Rights​ ​Law​ ​and​ ​any​ ​other​ ​laws​​and/or​​regulations​ ​relating​​to​​employment​​or​​employment​​discrimination,​​including,​​without​​limitation,​​claims​​based​​on​​age​​or​​under​​the​ ​Age​​Discrimination​​in​​Employment​​Act​​or​​Older​​Workers​​Benefit​​Protection​​Act,​​and/or​​claims​​based​​on​​disability​​or​ ​under the Americans with Disabilities Act.​ ​b. ​You​ ​hereby​ ​acknowledge​ ​that​ ​you​ ​are​ ​aware​ ​of​ ​the​ ​principle​ ​that​ ​a​​general​​release​​does​​not ​extend​​to​​claims​​that​​the​​releasor​​does​​not​​know​​or​​suspect​​to​​exist​​in​​his​​or​​her​​favor​​at​​the​​time​​of​​executing​​the​ ​release,​ ​which,​ ​if​ ​known​ ​by​ ​him​​or​​her,​​must​​have​​materially​​affected​​his​​or​​her​​settlement​​with​​the​​releasee.​​With​ ​knowledge of this principle, you hereby agree to expressly waive any rights you may have to that effect.​ ​You​​further​​acknowledge​​that​​you​​waive​​all​​rights​​afforded​​by​​Section​​1542​​of​​the​​Civil​​Code​​of​​the​ ​State​​of​​California​​(“Section​​1542”),​​or​​any​​other​​law​​or​​statute​​of​​similar​​effect​​in​​any​​jurisdiction​​with​​respect​​to​​the​ ​released Claims, with respect to the Releasees. Section 1542 states:​ ​“A​ ​GENERAL​ ​RELEASE​ ​DOES​ ​NOT​ ​EXTEND​ ​TO​ ​CLAIMS​ ​THAT​ ​THE​ ​CREDITOR​ ​OR​ ​RELEASING​ ​PARTY​ ​DOES​ ​NOT​ ​KNOW​ ​OR​ ​SUSPECT​ ​TO​​EXIST​​IN​​HIS​​OR​​HER​​FAVOR​​AT​ ​THE​​TIME​​OF​​EXECUTING​​THE​​RELEASE,​​THAT​​IF​​KNOWN​​BY​​HIM​​OR​​HER​​WOULD​​HAVE​ ​MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”​ ​Notwithstanding​ ​the​ ​provisions​ ​of​ ​Section​ ​1542​ ​and​ ​for​ ​the​ ​purpose​ ​of​ ​implementing​ ​a​ ​full​ ​and​ ​complete​​release​​of​​all​ ​claims,​​you​​acknowledge​​and​​agree​​that​​this​​Agreement​​releases​​all​​claims​​existing​​or​​arising​ ​prior​​to​​your​​execution​​of​​this​​Agreement​​which​​you​​have​​or​​suspect​​you​​may​​have​​against​​the​​Releasees​​whether​ ​such​ ​claims​ ​are​ ​known​ ​or​ ​unknown​ ​and​​suspected​​or​​unsuspected​​by​​you​​and​​you​​forever​​waive​​all​ ​inquiries​​and​ ​investigations​​into​​any​​and​​all​​such​​claims.​ ​You​​understand​​and​​acknowledge​​that​​the​​significance​​and​​consequence​ ​of​​this​​waiver​​of​​Civil​ ​Code​​§1542,​​is​​that​​even​​if​​you​​should​​suffer​​additional​​injuries​​or​​damages​​arising​​out​​of​​the​ ​released claims, you will not be permitted to make any claim for those injuries or damages.​ ​c. ​You​​and​​the​​Company​​do​​not​​intend​​to​​release​​claims​​that​​you​​may​​not​​release​​as​​a​​matter​​of ​law,​​including​​but​​not​​limited​​to​​claims​​for​​indemnity,​​and​​any​​claims​​for​​enforcement​​of​​this​​Agreement.​​To​​the​​fullest​ ​extent​​permitted​​by​​law,​​any​​dispute​​regarding​​the​​scope​​of​​this​​general​​release​​shall​​be​​determined​​by​​an​​arbitrator​ ​under the procedures set forth in the arbitration clause below.​ ​8.​​Covenant Not to Sue​​: ​a. ​To​​the​​fullest​​extent​​permitted​​by​​law,​​at​​no​​time​​subsequent​​to​​the​​execution​​of​​this​​Agreement ​will​ ​you​ ​pursue,​ ​or​ ​cause​ ​or​ ​knowingly​ ​permit​ ​the​​prosecution,​​in​​any​​state,​​federal​​or​​foreign​​court,​​or​​before​​any​ ​local,​ ​state,​ ​federal​ ​or​ ​foreign​​administrative​​agency,​​or​​any​​other​​tribunal,​​any​​charge,​​claim​​or​​action​​of​​any​​kind,​ ​nature​​and​​character​​whatsoever,​​known​​or​​unknown,​​which​​you​​may​​now​​have,​​have​​ever​​had,​​or​​may​​in​​the​​future​ ​have against Releasees, which is based in whole or in part on any matter covered by this Agreement.​ ​b.Nothing​ ​in​ ​this​ ​section​ ​shall​ ​prohibit​ ​you​ ​from​ ​filing​ ​a​ ​charge​ ​or​ ​complaint​ ​with​ ​a​ ​government ​agency​ ​where,​ ​as​ ​a​ ​matter​ ​of​ ​law,​ ​the​ ​parties​ ​may​ ​not​ ​restrict​ ​your​ ​ability​ ​to​ ​file​ ​such​ ​administrative​ ​complaints.​ ​However,​ ​you​ ​understand​ ​and​​agree​​that,​​by​​entering​​into​​this​​Agreement,​​you​​are​​releasing​​any​​and​​all​​individual​ ​claims​​for​​relief,​​and​​that​​any​​and​​all​​subsequent​​disputes​​between​​you​​and​​the​​Company​​shall​​be​​resolved​​through​ ​arbitration as provided below.​ ​c.Nothing​ ​in​ ​this​ ​section​ ​shall​ ​prohibit​ ​or​ ​impair​ ​you​ ​or​ ​the​ ​Company​ ​from​ ​complying​ ​with​ ​all ​applicable​ ​laws,​ ​nor​ ​shall​ ​this​ ​Agreement​ ​be​ ​construed​ ​to​ ​obligate​ ​either​ ​party​ ​to​ ​commit​ ​(or​ ​aid​ ​or​ ​abet​ ​in​ ​the​ ​commission of) any unlawful act.​ ​9.​​Nondisparagement​​:​ ​You​​agree​​that​​you​​will​ ​not​​disparage​​Releasees​​or​​their​​products,​​services,​​agents, ​representatives,​​directors,​​officers,​​shareholders,​​attorneys,​​employees,​​vendors,​​affiliates,​​successors​​or​​assigns,​​or​ ​any​​person​​acting​​by,​​through,​​under​​or​​in​​concert​​with​​any​​of​​them,​​with​​any​​written​​or​​oral​​statement.​​Nothing​​in​​this​ Exhibit 10.2

 
​paragraph​ ​shall​ ​prohibit​ ​you​ ​from​ ​providing​ ​truthful​ ​information​ ​in​ ​response​ ​to​​a​​subpoena​​or​​other​​legal​​process.​ ​Notwithstanding​ ​the​ ​foregoing,​ ​nothing​ ​in​ ​this​​Agreement​​precludes​​or​​otherwise​​limits​​your​​ability​​to​​communicate​ ​directly​​with​​and​​provide​​information,​​including​​documents,​​not​​otherwise​​protected​​from​​disclosure​​by​​any​​applicable​ ​law​ ​or​ ​privilege​ ​to​ ​the​ ​Securities​ ​and​ ​Exchange​ ​Commission​ ​(the​ ​“SEC”),​ ​or​ ​any​ ​other​ ​federal,​ ​state​ ​or​ ​local​ ​governmental​​agency​​or​​commission​​or​​self-regulatory​​organization​​(each​​such​​agency,​​commission​​or​​organization,​ ​a​​“Government​​Agency”)​​or​​self-regulatory​​organization​​regarding​​possible​​legal​​violations,​​without​​disclosure​​to​​the​ ​Company.​​You​​do​​not​​need​​the​​prior​​authorization​​of​​the​​Company​​to​​make​​any​​such​​reports​​or​​disclosures,​​and​​you​ ​shall​​not​​be​​required​​to​​notify​​the​​Company​​that​​such​​reports​​or​​disclosures​​have​​been​​made.​​The​​Company​​may​​not​ ​retaliate​ ​against​ ​you​ ​for​ ​any​​of​​these​​activities,​​and​​nothing​​in​​this​​Agreement​​requires​​you​​to​​waive​​any​​monetary​ ​award or other relief that you might become entitled to from the SEC or any other Government Agency.​ ​10.​​Arbitration​​:​ ​Except​ ​for​ ​any​ ​claim​ ​for​ ​injunctive​ ​relief​ ​arising​ ​out​ ​of​ ​a​ ​breach​ ​of​ ​a​​party’s​​obligations​​to ​protect​​the​​other’s​​proprietary​​information,​​the​​parties​​agree​​to​​arbitrate,​​in​​County,​​New​​York,​​any​​and​​all​​disputes​​or​ ​claims​​arising​​out​​of​​or​​related​​to​​the​​validity,​​enforceability,​​interpretation,​​performance​​or​​breach​​of​​this​​Agreement,​ ​whether​​sounding​​in​​tort,​​contract,​​statutory​​violation​​or​​otherwise,​​or​​involving​​the​​construction​​or​​application​​or​​any​ ​of​​the​​terms,​​provisions,​​or​​conditions​​of​​this​​Agreement.​​Any​​arbitration​​may​​be​​initiated​​by​​a​​written​​demand​​to​​the​ ​other​ ​party.​ ​The​ ​arbitrator's​ ​decision​ ​shall​ ​be​ ​final,​ ​binding,​ ​and​ ​conclusive.​ ​The​ ​parties​ ​further​ ​agree​ ​that​ ​this​ ​Agreement​​is​​intended​​to​​be​​strictly​​construed​​to​​provide​​for​​arbitration​​as​​the​​sole​​and​​exclusive​​means​​for​​resolution​ ​of​​all​ ​disputes​​hereunder​​to​​the​​fullest​​extent​​permitted​​by​​law.​​The​​parties​​expressly​​waive​​any​​entitlement​​to​​have​ ​such controversies decided by a court or a jury.​ ​11.​​Attorneys’​​Fees​​:​​If​​any​​action​​is​​brought​​to​​enforce​​the​​terms​​of​​this​​Agreement,​​the​​prevailing​​party​​will ​be​​entitled​​to​​recover​​its​​reasonable​​attorneys’​​fees,​​costs​​and​​expenses​​from​​the​​other​​party,​​in​​addition​​to​​any​​other​ ​relief to which the prevailing party may be entitled.​ ​12.​​Confidentiality​​:​ ​Except​ ​as​ ​required​ ​by​ ​applicable​ ​law,​ ​the​ ​contents,​ ​terms​ ​and​ ​conditions​ ​of​ ​this ​Agreement​​must​​be​​kept​​confidential​​by​​you​​and​​may​​not​​be​​disclosed​​except​​to​​your​​immediate​​family,​​accountant​​or​ ​attorneys​ ​or​ ​pursuant​ ​to​ ​subpoena​ ​or​ ​court​ ​order.​ ​You​ ​agree​ ​that​ ​if​ ​you​​are​​asked​​for​​information​​concerning​​this​ ​Agreement,​​you​​will​ ​state​​only​​that​​you​​and​​the​​Company​​reached​​an​​amicable​​resolution​​of​​any​​disputes​​concerning​ ​your​​separation​​from​​the​​Company.​​Any​​breach​​of​​this​​confidentiality​​provision​​shall​​be​​deemed​​a​​material​​breach​​of​ ​this Agreement.​ ​13.​​No​​Admission​​of​​Liability​​:​​This​​Agreement​​is​​not​​and​​shall​​not​​be​​construed​​or​​contended​​by​​you​​to​​be​​an ​admission​​or​​evidence​​of​​any​​wrongdoing​​or​​liability​​on​​the​​part​​of​​Releasees,​​their​​representatives,​​heirs,​​executors,​ ​attorneys,​​agents,​​partners,​​officers,​​shareholders,​​directors,​​employees,​​subsidiaries,​​affiliates,​​divisions,​​successors​ ​or​​assigns.​​This​​Agreement​​shall​​be​​afforded​​the​​maximum​​protection​​allowable​​under​​the​​Federal​​Rules​​of​​Evidence​ ​408 and/or any other state or federal provisions of similar effect.​ ​14.​​Complete​ ​and​ ​Voluntary​ ​Agreement​​:​ ​This​ ​Agreement,​ ​together​ ​with​ ​Exhibit​ ​A​ ​hereto​ ​and​ ​any​ ​equity ​award​ ​agreements,​ ​constitute​ ​the​​entire​​agreement​​between​​you​​and​​Releasees​​with​​respect​​to​​the​​subject​​matter​ ​hereof​​and​​supersedes​​all​​prior​​negotiations​​and​​agreements,​​whether​​written​​or​​oral,​​relating​​to​​such​​subject​​matter.​ ​You​ ​acknowledge​ ​that​ ​neither​ ​Releasees​ ​nor​ ​their​ ​agents​ ​or​ ​attorneys​​have​​made​​any​​promise,​​representation​​or​ ​warranty​ ​whatsoever,​ ​either​ ​express​ ​or​ ​implied,​ ​written​ ​or​ ​oral,​ ​which​ ​is​ ​not​ ​contained​ ​in​ ​this​ ​Agreement​ ​for​ ​the​ ​purpose of inducing you to execute the Agreement, and you acknowledge that you have executed this Agreement in​ ​reliance​ ​only​ ​upon​ ​such​ ​promises,​ ​representations​ ​and​ ​warranties​ ​as​ ​are​ ​contained​ ​herein,​ ​and​ ​that​ ​you​ ​are​ ​executing this Agreement voluntarily, free of any duress or coercion.​ ​15.​​Severability​​:​​The​​provisions​​of​​this​​Agreement​​are​​severable,​​and​​if​​any​​part​​of​​it​​is​​found​​to​​be​​invalid​​or ​unenforceable,​ ​the​ ​other​ ​parts​ ​shall​ ​remain​ ​fully​ ​valid​ ​and​ ​enforceable.​ ​Specifically,​ ​should​ ​a​ ​court,​ ​arbitrator,​ ​or​ ​government​​agency​​conclude​​that​​a​​particular​​claim​​may​​not​​be​​released​​as​​a​​matter​​of​​law,​​it​​is​​the​​intention​​of​​the​ ​parties​ ​that​ ​the​ ​general​ ​release,​ ​the​ ​waiver​​of​​unknown​​claims​​and​​the​​covenant​​not​​to​​sue​​above​​shall​​otherwise​ ​remain effective to release any and all other claims.​ ​16.​​Modification;​​Counterparts;​​Facsimile/PDF​​Signatures​​:​​It​​is​​expressly​​agreed​​that​​this​​Agreement​​may​​not ​be​ ​altered,​ ​amended,​ ​modified,​ ​or​ ​otherwise​ ​changed​ ​in​ ​any​ ​respect​ ​except​ ​by​ ​another​ ​written​ ​agreement​ ​that​ ​specifically​​refers​​to​​this​​Agreement,​​executed​​by​​authorized​​representatives​​of​​each​​of​​the​​parties​​to​​this​​Agreement.​ ​This​​Agreement​​may​​be​​executed​​in​​any​​number​​of​​counterparts,​​each​​of​​which​​shall​​constitute​​an​​original​​and​​all​​of​ ​which​ ​together​ ​shall​ ​constitute​ ​one​ ​and​ ​the​​same​​instrument.​​Execution​​of​​a​​facsimile​​or​​PDF​​copy​​shall​​have​​the​ Exhibit 10.2

 
​same​ ​force​​and​​effect​​as​​execution​​of​​an​​original,​​and​​a​​copy​​of​​a​​signature​​will​ ​be​​equally​​admissible​​in​​any​​legal​ ​proceeding as if an original.​ ​17.​​Review​ ​of​ ​Separation​ ​Agreement​​:​ ​You​ ​understand​ ​that​ ​you​ ​may​ ​take​ ​up​ ​to​ ​twenty-one​ ​(21)​ ​days​ ​to ​consider​ ​this​ ​Agreement​ ​and,​ ​by​ ​signing​ ​below,​ ​affirm​ ​that​ ​you​ ​were​ ​advised​ ​to​ ​consult​ ​with​ ​an​ ​attorney​ ​prior​ ​to​ ​signing​ ​this​ ​agreement.​ ​You​ ​also​ ​understand​​you​​may​​revoke​​this​​Agreement​​within​​seven​​(7)​​days​​of​​signing​​this​ ​document​​and​​that​​the​​compensation​​to​​be​​paid​​to​​you​​pursuant​​to​​Paragraph​​3​​will​ ​be​​paid​​only​​at​​the​​end​​of​​that​ ​seven (7) day revocation period.​ ​18.​​Effective​​Date​​:​​This​​Agreement​​is​​effective​​on​​the​​eighth​​(8th)​​day​​after​​you​​sign​​it​​and​​without​​revocation ​by you.​ ​19.​​Governing​​Law​​:​​This​​Agreement​​shall​​be​​governed​​by​​and​​construed​​in​​accordance​​with​​the​​laws​​of​​the ​State of New York.​ ​If​ ​you​ ​agree​ ​to​ ​abide​ ​by​ ​the​ ​terms​ ​outlined​ ​in​ ​this​ ​letter,​ ​please​ ​sign​ ​this​ ​letter​ ​below​ ​and​ ​also​ ​sign​​the​ ​attached copy and return it to me. I wish you the best in your future endeavors.​ ​Sincerely,​ ​MongoDB, Inc.​ ​By: _______________________________​ ​[Name and title of person signing on behalf of the​ ​Company]​ ​READ, UNDERSTOOD AND AGREED​ ​CJ Desai: ____________________________ Date: _____________________________​ Exhibit 10.2